
Annual report 2025
added 02-23-2026
Hims & Hers Health Revenue 2011-2026 | HIMS
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue Hims & Hers Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.35 B | 1.48 B | 872 M | 527 M | 272 M | 149 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.35 B | 149 M | 941 M |
Quarterly Revenue Hims & Hers Health
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 599 M | 545 M | 586 M | 402 M | 316 M | 278 M | 227 M | 208 M | 191 M | - | 145 M | 114 M | 101 M | - | 74.2 M | 60.7 M | 52.3 M | - | 41.3 M | 35.9 M | 30.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 599 M | 30.1 M | 222 M |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Household products industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Natura &Co Holding S.A.
NTCO
|
26.7 B | - | - | $ 9.02 B | - | |
|
Colgate-Palmolive Company
CL
|
20.4 B | $ 84.34 | -2.0 % | $ 68.2 B | ||
|
The Clorox Company
CLX
|
7.1 B | $ 105.28 | -2.17 % | $ 13 B | ||
|
Church & Dwight Co.
CHD
|
6.2 B | $ 95.42 | -0.77 % | $ 23.2 B | ||
|
Inter Parfums
IPAR
|
1.49 B | $ 93.0 | 1.44 % | $ 2.99 B | ||
|
e.l.f. Beauty
ELF
|
321 M | $ 65.13 | 1.88 % | $ 3.57 B | ||
|
Kimberly-Clark Corporation
KMB
|
4.08 B | $ 97.28 | -0.69 % | $ 32.3 B | ||
|
Helen of Troy Limited
HELE
|
1.91 B | $ 16.73 | -1.47 % | $ 385 M | ||
|
LifeVantage Corporation
LFVN
|
229 M | - | - | $ 50.8 M | ||
|
Coty
COTY
|
5.89 B | $ 2.17 | 3.58 % | $ 1.89 B | ||
|
The Estée Lauder Companies
EL
|
14.3 B | $ 72.67 | -0.85 % | $ 26.2 B | ||
|
Mannatech, Incorporated
MTEX
|
132 M | $ 5.63 | -10.0 % | $ 10.5 M | ||
|
Nature's Sunshine Products
NATR
|
480 M | $ 26.93 | -0.44 % | $ 485 M | ||
|
Newell Brands
NWL
|
7.2 B | $ 3.89 | -1.77 % | $ 1.63 B | ||
|
Nu Skin Enterprises
NUS
|
1.73 B | $ 7.52 | -1.57 % | $ 371 M | ||
|
Edgewell Personal Care Company
EPC
|
2.25 B | $ 21.89 | -2.01 % | $ 1.09 B | ||
|
Acme United Corporation
ACU
|
197 M | $ 44.81 | -2.35 % | $ 170 M | ||
|
United-Guardian
UG
|
10.5 M | $ 6.55 | -0.98 % | $ 30.1 M | ||
|
The Procter & Gamble Company
PG
|
84.3 B | $ 145.16 | -1.02 % | $ 341 B | ||
|
Unilever PLC
UL
|
50.5 B | $ 58.34 | -0.21 % | $ 132 B | ||
|
Spectrum Brands Holdings
SPB
|
2.81 B | $ 79.04 | -1.47 % | $ 2.03 B | ||
|
Revlon
REV
|
2.08 B | - | -4.41 % | $ 212 M | ||
|
Dogness (International) Corporation
DOGZ
|
27.1 M | $ 1.26 | -6.67 % | $ 42.5 M | ||
|
USANA Health Sciences
USNA
|
925 M | $ 18.11 | -1.25 % | $ 336 M |